NCT00255346 2025-12-30Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)M.D. Anderson Cancer CenterPhase 2 Completed68 enrolled 13 charts
NCT01384513 2022-11-17A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThomas Jefferson UniversityPhase 2 Completed40 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled